Thrombotic thrombocytopenic purpura (TTP)-like syndrome in the HIV era.

HIV-related TTP is still a cause of morbidity and the clinical presentation is heterogeneous which may present a diagnostic challenge in the absence of sensitive biomarkers. Early treatment with plasma exchange is effective but expensive and invasive.